Acon Mamp One Step Methamphetamine Test Strip, Acon Mamp One Step Methamphetamine Test Device
Gas Chromatography, Methamphetamine. 510(k) K011672, from ACON Laboratories, Inc. (San Diego, CA). Product code LAF, class 2.
As of Nov 22, 2026, K011672 is an FDA 510(k) held by ACON Laboratories, Inc., substantially equivalent on Jul 31, 2001 after 62 days, with no recalls tied to it in FDA's recall database.
- Review time: 62 days
- Recalls: 0
- Cited as a predicate by: 3 devices
ACON mAMP One Step Methamphetamine Test Strip and ACON mAMP One Step Methamphetamine Test Device are rapid chromatographic immunoassays for the qualitative detection of methamphetamine in human urine at a cut-off concentration of 1,000 ng/mL. It is intended for professional and point of care use.
- Accusign Met/Biosign MetK961249 · Princeton BioMeditech Corp. · Apr 25, 1996
- Rapidsense Drugs of Abuse Methamphetamine (Met) 1000 Device, Model 900-0050K080455 · Quantrx Biomedical Corporation · Dec 31, 2008
- Nano-Check Dat 5 Multi Drug Screening Test for Cannabinoids, Opiates, Cocaine, Methamphetamine & PhencyclidineK050594 · Nano-Ditech Co. · May 15, 2005
- Acon One Step Multi-Drug Multi-Line Screen Test Card; Acon One Step Multi-Drug Multi-Line Screen Test DeviceK020313 · Acon Laboratories Co. · May 8, 2002
- SEFRIA Methamphetamine Oral Fluid Enzyme ImmunoassayK203647 · Immunalysis Corporation · Dec 22, 2021
- Psychemedics Homogeneous Enzyme Immunoassay for Amphetamines in HairK210212 · Psychemedics Corporation · Dec 15, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 30, 2001
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3610
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files